Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

OTC Healthcare in the Czech Republic to 2011

Published by: Datamonitor

Published: Jul. 31, 2008 - 194 Pages


Table of Contents


Chapter 1 EXECUTIVE SUMMARY
Summary Market Level - OTC Healthcare
Summary category level - Analgesics
Summary category level - Cough and Cold Preparations
Summary category level - Traditional Medicines
Summary category level - First Aid Kits
Summary category level - Indigestion Preparations
Summary category level - Vitamins and Minerals
Summary category level - Plasters & Bandages
Summary category level - Medicated Skin Products
Summary category level - Other OTC Healthcare Products
Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
What is this report about?
How to use this report
Market Definition
Chapter 3 MARKET OVERVIEW
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
Pfizer Inc
GlaxoSmithKline Plc
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
Value Analysis, 2001-2006
Value Analysis, 2006-2011
Value Analysis, US$ 2001-2006
Value Analysis, US$ 2006-2011
Company and Brand Share Analysis
Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
Value
Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
Product launches over time
Recent product launches
Chapter 17 CZECH REPUBLIC SOCIOECONOMIC PROFILE
Country Overview
Key Facts
Political Overview
The Czech Republic Economic Overview
Chapter 18 CZECH REPUBLIC MACROECONOMIC PROFILE
Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modelling
Primary research
Data finalisation
Ongoing research
Chapter 20 APPENDIX
Future readings
How to contact experts in your industry
LIST OF FIGURES
Figure 1: Czech Republic OTC Healthcare value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 2: Czech Republic OTC Healthcare category growth comparison, by value, 2001-2011
Figure 3: Czech Republic OTC Healthcare company share, by value, 2005-2006 (%)
Figure 4: Czech Republic Analgesics value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 5: Czech Republic Analgesics category growth comparison, by value, 2001-2011
Figure 6: Czech Republic Analgesics company share, by value, 2005-2006 (%)
Figure 7: Czech Republic Cough and Cold Preparations value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 8: Czech Republic Cough and Cold Preparations category growth comparison, by value, 2001-2011
Figure 9: Czech Republic Cough and Cold Preparations company share, by value, 2005-2006 (%)
Figure 10: Czech Republic Traditional Medicines value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 11: Czech Republic Traditional Medicines company share, by value, 2005-2006 (%)
Figure 12: Czech Republic First Aid Kits value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 13: Czech Republic Indigestion Preparations value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 14: Czech Republic Indigestion Preparations category growth comparison, by value, 2001-2011
Figure 15: Czech Republic Indigestion Preparations company share, by value, 2005-2006 (%)
Figure 16: Czech Republic Vitamins and Minerals value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 17: Czech Republic Vitamins and Minerals category growth comparison, by value, 2001-2011
Figure 18: Czech Republic Vitamins and Minerals company share, by value, 2005-2006 (%)
Figure 19: Czech Republic Plasters & Bandages value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 20: Czech Republic Plasters & Bandages category growth comparison, by value, 2001-2011
Figure 21: Czech Republic Plasters & Bandages company share, by value, 2005-2006 (%)
Figure 22: Czech Republic Medicated Skin Products value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 23: Czech Republic Medicated Skin Products category growth comparison, by value, 2001-2011
Figure 24: Czech Republic Medicated Skin Products company share, by value, 2005-2006 (%)
Figure 25: Czech Republic Other OTC Healthcare Products value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 26: Czech Republic Other OTC Healthcare Products category growth comparison, by value, 2001-2011
Figure 27: Czech Republic Other OTC Healthcare Products company share, by value, 2005-2006 (%)
Figure 28: Czech Republic Topical OTC Medicines value & value forecast, 2001-2011 (CZK m, nominal prices)
Figure 29: Czech Republic Topical OTC Medicines category growth comparison, by value, 2001-2011
Figure 30: Czech Republic Topical OTC Medicines company share, by value, 2005-2006 (%)
Figure 31: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries
Figure 32: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries)
Figure 33: Map of the Czech Republic
Figure 34: Annual data review process
LIST OF TABLES
Table 1: OTC Healthcare category definitions
Table 2: Czech Republic OTC Healthcare value, 2001-2006 (CZK m, nominal prices)
Table 3: Czech Republic OTC Healthcare value forecast, 2006-2011 (CZK m, nominal prices)
Table 4: Czech Republic OTC Healthcare value, 2001-2006 (US$ m nominal prices)
Table 5: Czech Republic OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices)
Table 6: Czech Republic OTC Healthcare brand share, by value, 2005-2006 (%)
Table 7: Czech Republic OTC Healthcare value, by brand 2005-2006 (CZK m nominal prices)
Table 8: Czech Republic OTC Healthcare company share by value, 2005-2006 (%)
Table 9: Czech Republic OTC Healthcare value, by company, 2005-2006 (CZK m nominal prices)
Table 10: Czech Republic OTC Healthcare expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 11: Czech Republic OTC Healthcare forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 12: Czech Republic OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices)
Table 13: Czech Republic OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 14: Pfizer Inc Key Facts
Table 15: GlaxoSmithKline Plc Key Facts
Table 16: Czech Republic Analgesics value, 2001-2006 (CZK m, nominal prices)
Table 17: Czech Republic Analgesics value forecast, 2006-2011 (CZK m, nominal prices)
Table 18: Czech Republic Analgesics value, 2001-2006 (US$ m nominal prices)
Table 19: Czech Republic Analgesics value forecast, 2006-2011 (US$ m nominal prices)
Table 20: Czech Republic Analgesics brand share, by value, 2005-2006 (%)
Table 21: Czech Republic Analgesics value, by brand 2005-2006 (CZK m nominal prices)
Table 22: Czech Republic Analgesics company share by value, 2005-2006 (%)
Table 23: Czech Republic Analgesics value, by company, 2005-2006 (CZK m nominal prices)
Table 24: Czech Republic Analgesics expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 25: Czech Republic Analgesics forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 26: Czech Republic Analgesics expenditure per capita, 2001-2006 (US$ nominal prices)
Table 27: Czech Republic Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 28: Czech Republic Cough and Cold Preparations value, 2001-2006 (CZK m, nominal prices)
Table 29: Czech Republic Cough and Cold Preparations value forecast, 2006-2011 (CZK m, nominal prices)
Table 30: Czech Republic Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices)
Table 31: Czech Republic Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 32: Czech Republic Cough and Cold Preparations brand share, by value, 2005-2006 (%)
Table 33: Czech Republic Cough and Cold Preparations value, by brand 2005-2006 (CZK m nominal prices)
Table 34: Czech Republic Cough and Cold Preparations company share by value, 2005-2006 (%)
Table 35: Czech Republic Cough and Cold Preparations value, by company, 2005-2006 (CZK m nominal prices)
Table 36: Czech Republic Cough and Cold Preparations expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 37: Czech Republic Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 38: Czech Republic Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 39: Czech Republic Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 40: Czech Republic Traditional Medicines value, 2001-2006 (CZK m, nominal prices)
Table 41: Czech Republic Traditional Medicines value forecast, 2006-2011 (CZK m, nominal prices)
Table 42: Czech Republic Traditional Medicines value, 2001-2006 (US$ m nominal prices)
Table 43: Czech Republic Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 44: Czech Republic Traditional Medicines brand share, by value, 2005-2006 (%)
Table 45: Czech Republic Traditional Medicines value, by brand 2005-2006 (CZK m nominal prices)
Table 46: Czech Republic Traditional Medicines company share by value, 2005-2006 (%)
Table 47: Czech Republic Traditional Medicines value, by company, 2005-2006 (CZK m nominal prices)
Table 48: Czech Republic Traditional Medicines expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 49: Czech Republic Traditional Medicines forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 50: Czech Republic Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 51: Czech Republic Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 52: Czech Republic First Aid Kits value, 2001-2006 (CZK m, nominal prices)
Table 53: Czech Republic First Aid Kits value forecast, 2006-2011 (CZK m, nominal prices)
Table 54: Czech Republic First Aid Kits value, 2001-2006 (US$ m nominal prices)
Table 55: Czech Republic First Aid Kits value forecast, 2006-2011 (US$ m nominal prices)
Table 56: Czech Republic First Aid Kits brand share, by value, 2005-2006 (%)
Table 57: Czech Republic First Aid Kits value, by brand 2005-2006 (CZK m nominal prices)
Table 58: Czech Republic First Aid Kits company share by value, 2005-2006 (%)
Table 59: Czech Republic First Aid Kits value, by company, 2005-2006 (CZK m nominal prices)
Table 60: Czech Republic First Aid Kits expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 61: Czech Republic First Aid Kits forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 62: Czech Republic First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices)
Table 63: Czech Republic First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 64: Czech Republic Indigestion Preparations value, 2001-2006 (CZK m, nominal prices)
Table 65: Czech Republic Indigestion Preparations value forecast, 2006-2011 (CZK m, nominal prices)
Table 66: Czech Republic Indigestion Preparations value, 2001-2006 (US$ m nominal prices)
Table 67: Czech Republic Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices)
Table 68: Czech Republic Indigestion Preparations brand share, by value, 2005-2006 (%)
Table 69: Czech Republic Indigestion Preparations value, by brand 2005-2006 (CZK m nominal prices)
Table 70: Czech Republic Indigestion Preparations company share by value, 2005-2006 (%)
Table 71: Czech Republic Indigestion Preparations value, by company, 2005-2006 (CZK m nominal prices)
Table 72: Czech Republic Indigestion Preparations expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 73: Czech Republic Indigestion Preparations forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 74: Czech Republic Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices)
Table 75: Czech Republic Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 76: Czech Republic Vitamins and Minerals value, 2001-2006 (CZK m, nominal prices)
Table 77: Czech Republic Vitamins and Minerals value forecast, 2006-2011 (CZK m, nominal prices)
Table 78: Czech Republic Vitamins and Minerals value, 2001-2006 (US$ m nominal prices)
Table 79: Czech Republic Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices)
Table 80: Czech Republic Vitamins and Minerals brand share, by value, 2005-2006 (%)
Table 81: Czech Republic Vitamins and Minerals value, by brand 2005-2006 (CZK m nominal prices)
Table 82: Czech Republic Vitamins and Minerals company share by value, 2005-2006 (%)
Table 83: Czech Republic Vitamins and Minerals value, by company, 2005-2006 (CZK m nominal prices)
Table 84: Czech Republic Vitamins and Minerals expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 85: Czech Republic Vitamins and Minerals forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 86: Czech Republic Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices)
Table 87: Czech Republic Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 88: Czech Republic Plasters & Bandages value, 2001-2006 (CZK m, nominal prices)
Table 89: Czech Republic Plasters & Bandages value forecast, 2006-2011 (CZK m, nominal prices)
Table 90: Czech Republic Plasters & Bandages value, 2001-2006 (US$ m nominal prices)
Table 91: Czech Republic Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices)
Table 92: Czech Republic Plasters & Bandages brand share, by value, 2005-2006 (%)
Table 93: Czech Republic Plasters & Bandages value, by brand 2005-2006 (CZK m nominal prices)
Table 94: Czech Republic Plasters & Bandages company share by value, 2005-2006 (%)
Table 95: Czech Republic Plasters & Bandages value, by company, 2005-2006 (CZK m nominal prices)
Table 96: Czech Republic Plasters & Bandages expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 97: Czech Republic Plasters & Bandages forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 98: Czech Republic Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices)
Table 99: Czech Republic Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 100: Czech Republic Medicated Skin Products value, 2001-2006 (CZK m, nominal prices)
Table 101: Czech Republic Medicated Skin Products value forecast, 2006-2011 (CZK m, nominal prices)
Table 102: Czech Republic Medicated Skin Products value, 2001-2006 (US$ m nominal prices)
Table 103: Czech Republic Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices)
Table 104: Czech Republic Medicated Skin Products brand share, by value, 2005-2006 (%)
Table 105: Czech Republic Medicated Skin Products value, by brand 2005-2006 (CZK m nominal prices)
Table 106: Czech Republic Medicated Skin Products company share by value, 2005-2006 (%)
Table 107: Czech Republic Medicated Skin Products value, by company, 2005-2006 (CZK m nominal prices)
Table 108: Czech Republic Medicated Skin Products expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 109: Czech Republic Medicated Skin Products forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 110: Czech Republic Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 111: Czech Republic Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 112: Czech Republic Other OTC Healthcare Products value, 2001-2006 (CZK m, nominal prices)
Table 113: Czech Republic Other OTC Healthcare Products value forecast, 2006-2011 (CZK m, nominal prices)
Table 114: Czech Republic Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices)
Table 115: Czech Republic Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices)
Table 116: Czech Republic Other OTC Healthcare Products brand share, by value, 2005-2006 (%)
Table 117: Czech Republic Other OTC Healthcare Products value, by brand 2005-2006 (CZK m nominal prices)
Table 118: Czech Republic Other OTC Healthcare Products company share by value, 2005-2006 (%)
Table 119: Czech Republic Other OTC Healthcare Products value, by company, 2005-2006 (CZK m nominal prices)
Table 120: Czech Republic Other OTC Healthcare Products expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 121: Czech Republic Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 122: Czech Republic Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices)
Table 123: Czech Republic Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 124: Czech Republic Topical OTC Medicines value, 2001-2006 (CZK m, nominal prices)
Table 125: Czech Republic Topical OTC Medicines value forecast, 2006-2011 (CZK m, nominal prices)
Table 126: Czech Republic Topical OTC Medicines value, 2001-2006 (US$ m nominal prices)
Table 127: Czech Republic Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices)
Table 128: Czech Republic Topical OTC Medicines brand share, by value, 2005-2006 (%)
Table 129: Czech Republic Topical OTC Medicines value, by brand 2005-2006 (CZK m nominal prices)
Table 130: Czech Republic Topical OTC Medicines company share by value, 2005-2006 (%)
Table 131: Czech Republic Topical OTC Medicines value, by company, 2005-2006 (CZK m nominal prices)
Table 132: Czech Republic Topical OTC Medicines expenditure per capita, 2001-2006 (CZK, nominal prices)
Table 133: Czech Republic Topical OTC Medicines forecast expenditure per capita, 2006-2011 (CZK, nominal prices)
Table 134: Czech Republic Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices)
Table 135: Czech Republic Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices)
Table 136: Global OTC Healthcare market value, 2006
Table 137: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries
Table 138: Leading players - Top 5 countries
Table 139: Czech Republic OTC Healthcare new product launches (reports) and SKUs, by company (Top 5 companies), 2006
Table 140: Czech Republic OTC Healthcare new product launches (reports), by flavor and fragrances 2006
Table 141: Czech Republic OTC Healthcare new product launches (reports), by Ingredients (Top 10 Ingredients), 2006
Table 142: Czech Republic OTC Healthcare new product launches (reports), by Package tags or Claims 2006
Table 143: Czech Republic OTC Healthcare new product launches (reports) - Recent 5 launches
Table 144: Czech Republic Key Facts
Table 145: Czech Republic population, by age group, 2000-2005 (millions)
Table 146: Czech Republic population forecast, by age group, 2005-2010 (millions)
Table 147: Czech Republic population, by gender, 2000-2005 (millions)
Table 148: Czech Republic population forecast, by gender, 2005-2010 (millions)
Table 149: Czech Republic real GDP, 2000-2005 (CZK bn, 2005 prices)
Table 150: Czech Republic real GDP forecast, 2005-2010 (CZK bn, 2005 prices)
Table 151: Czech Republic nominal GDP, 2000-2005 (CZK bn, nominal prices)
Table 152: Czech Republic real GDP, 2000-2005 (US$ bn, 2005 prices)
Table 153: Czech Republic real GDP forecast, 2005-2010 (US$ bn, 2005 prices)
Table 154: Czech Republic consumer price index, 2000-2005 (2000=100)
Table 155: Czech Republic consumer price index, 2005-2010 (2000=100)
Table 156: Czech Republic exchange rate, 2000-2005

Abstract

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in the Czech Republic. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope
  • Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
  • Provides market value, volume, expenditure and consumption data by market, segment and subsegment
  • Includes company and brand share data by categories
Highlights

The market for OTC Healthcare in the Czech Republic increased between 2001-2006, growing at an average annual rate of 5.9%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was GlaxoSmithKline Plc with Boiron SA in third place.

Reasons to Purchase
  • Discover the major quantitative trends affecting the OTC Healthcare markets
  • Understand consumers' consumption and expenditure patterns
  • Understand the future direction of the market with reliable historical data and full five year forecasting


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008